Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia Meeting Abstract


Authors: Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; Tallman, M. S.
Abstract Title: Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385006147
PROVIDER: wos
Notes: Meeting Abstract: 2876 -- Source: Wos
MSK Authors
  1. Mario E Lacouture
    276 Lacouture
  2. Julie T Feldstein
    288 Feldstein
  3. Martin Stuart Tallman
    443 Tallman
  4. Jae Hong Park
    149 Park
  5. Stephen Shiu-Wah Chung
    58 Chung
  6. Ross Levine
    492 Levine
  7. Michael Forman Berger
    393 Berger
  8. Helen Hyeong-Eun Won
    79 Won
  9. Young Rock Chung
    46 Chung
Related MSK Work